EPA and NanoLogix Enter Into Cooperative Research and Development Agreement for Rapid Water Quality Testing

  NanoLogix, Inc. (PINKSHEETS: NNLX) The U.S. Environmental Protection Agency announced it has entered into a Cooperative Research and Development Agreement (CRADA) with NanoLogix. The Agency and NanoLogix will work to design a rapid diagnostic method to detect bacterial threats, including E.coli and Cryptosporidium in drinking and source water. Scientists from the EPA and NanoLogix will use the company's rapid detection technology as a foundation for the new process, with the goal of significantly reduced test times from those achievable with current tests.

"Working with the EPA on water quality testing is a significant milestone in our corporate development," said NanoLogix CEO Bret Barnhizer. "It's been a long process to achieve this multi-year CRADA and we are pleased to be able to collaborate with the EPA on improving the safety and quality of the U.S. national water supply."

More on the EPA's announcement of the CRADA with NanoLogix can be found at:

http://www.epa.gov/microbes/mceardnews.html.

About NanoLogix, Inc. NanoLogix is a biotechnology company focused primarily on rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to medical and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing.

Patents granted to NanoLogix can be used in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity. For more information visit

www.nanologix.com

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Media Contact: Lisa Ann Pinkerton 650-288-1824 Email Contact Investor Contact: Carol Surrena NanoLogix, Inc. 330-534-0800 Email Contact